Nicotine Dependence Clinical Trial
Official title:
Study Two for Development of Novel Behavioral Intervention Mindfulness Training for Smokers
The MTS2 study enrollment goal is N=240 adult smokers randomized to study treatments. The study design includes two randomized arms to compare matched intensive interventions and a third non-randomized option for participants who prefer not to enter an intensive intervention. It is expected that roughly 50% (120) will choose to be in the randomized intensive interventions and 50% (120) will choose to be in the non-intensive intervention. Participants who choose to be in an intensive intervention will be randomized to either Mindfulness Training for Smokers(MTS) (n = 60) or Integrated Training for Smokers (ITS)(n=60). Both MTS and ITS are smoking cessation interventions that provide 8 classes over a 6-week period and 2 weeks of nicotine patches. MTS provides and training in mindfulness whereas ITS provides training in quit smoking strategies and access to the Freedom From Smoking Online Premium Program. Participants who choose to be in a non-intensive intervention (estimated from prior recruitment data at n=120) will receive a phone-based intervention through the Wisconsin Tobacco Quit Line and 2 weeks of nicotine patches.
The MTS2 Study is funded for through a five-year K23 NIH training grant (appendix) awarded to
Dr. James Davis, the Principal Investigator on this protocol. The study enrollment goal is
N=240 adult smokers randomized to study treatments. Based on prior recruitment numbers, it is
expected that roughly 50% (120) will choose to be in an intensive intervention and 50% (120)
will choose to be in the non-intensive intervention. Participants who choose to be in an
intensive intervention will be randomized to either MTS (n = 60) or ITS (n=60). MTS is a
smoking cessation intervention that provides 8 mindfulness classes over a 6-week period. ITS
will provide participants will access to the Freedom From Smoking Online Premium Program (at
no cost) plus 8 smoking cessation classes over a 6-week period. Participants who choose to be
in a non-intensive intervention (n=120) will receive a phone-based intervention through the
Wisconsin Tobacco Quit Line. At the Orientation Meeting, participants who decide to enter the
study will be allowed to choose whether they enter an intensive or the non-intensive
intervention. Intensive intervention participants will attend an additional meeting called
the Introductory Meeting where they are will undergo randomization into either the MTS or
ITS. The Introductory Meeting will also provide instruction on the use of nicotine patches,
smoking calendars and provide intervention materials. The study employs 3 study assessment
visits. Study Visit 1 follows the Orientation Meeting, Study Visit 2 is 4-weeks post-quit,
Study Visit 3 is 24-weeks post-quit. All participants will receive 2 weeks of free nicotine
patches and $30 for attending each of the two post-quit study visits.
The total time for the study including recruitment, intervention and participant follow-up
for N = 240 will be three years. The study will recruit subjects from the Dane county region
through the University of Wisconsin School of Medicine and Public Health Center for Tobacco
Research and Intervention (UW-CRTI). Recruitment will take place through flyers, television,
newspaper and radio advertisements.
The principal hypothesis for the study is that MTS compared to ITS will show significantly
higher point prevalent Carbon Monoxide confirmed smoking abstinence rates at 4 and 24 weeks
post quit. Secondary hypotheses is that study group compared to controls will show
significant differences in questionnaire results that test distress, depression, anxiety,
attentional control, mindfulness and quality of life and bio-physiological markers such as
weight, breath holding and hair cortisol.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05176418 -
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
|
Early Phase 1 | |
Completed |
NCT04084210 -
Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
|
Phase 2 | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Withdrawn |
NCT03707600 -
State and Trait Mediated Response to TMS in Substance Use Disorder
|
N/A | |
Recruiting |
NCT03999099 -
Targeting Orexin to Treat Nicotine Dependence
|
Phase 1 | |
Completed |
NCT03847155 -
Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery
|
N/A | |
Completed |
NCT02840435 -
Study on Sit to Quit Phone Intervention
|
N/A | |
Completed |
NCT02139930 -
Project 2: Strategies for Reducing Nicotine Content in Cigarettes
|
N/A | |
Completed |
NCT01926626 -
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
|
Phase 2 | |
Completed |
NCT01982110 -
A Mindfulness Based Application for Smoking Cessation
|
N/A | |
Withdrawn |
NCT01569477 -
Striving to Quit-Wisconsin Tobacco Quit Line
|
N/A | |
Completed |
NCT01632189 -
The Effect of Varenicline on D2/D3 Receptor Binding in Smokers
|
N/A | |
Completed |
NCT01685996 -
Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation
|
Phase 1/Phase 2 | |
Completed |
NCT01569490 -
Striving to Quit: First Breath
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT00996034 -
Nicotine Vaccination and Nicotinic Receptor Occupancy
|
Phase 2 | |
Completed |
NCT01061528 -
Coping Skills Treatment for Smoking Cessation
|
N/A | |
Suspended |
NCT01636336 -
Effects of Progesterone on Smoked Nicotine Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effects
|
N/A | |
Withdrawn |
NCT01589081 -
Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect
|
N/A | |
Completed |
NCT01943994 -
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
|
N/A |